INPLASY202420075

Efficacy of immunotherapy combined with chemotherapy in NSCLC patients with EGFR-TKI resistance: a meta-analysis of randomized clinical trials

Keywords: EGFR-Tyrosine Kinase Inhibitor, immunotherapy, chemotherapy ,NSCLC ,resistance

Review Status: Ongoing